New iron drug CTX001 put to the test in healthy volunteers
Knowledge-focused
Not yet recruiting
This early-stage study tests an experimental drug called CTX001 in 72 healthy adults. The goal is to check for side effects, how the body processes the drug, and how it affects iron levels when taken with or without food and iron. No direct treatment benefit is expected; the stud…
Phase: EARLY_PHASE1 • Sponsor: Cajal Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC